JOINT FILING AGREEMENTJoint Filing Agreement • December 20th, 2007 • Ra Capital Management, LLC • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agrees, as of December 20, 2007, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Neurocrine Biosciences, Inc., and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • December 11th, 2017 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of December 11, 2017, is by and among RA Capital Management, LLC and Peter Kolchinsky (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 14th, 2024 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 17th, 2018 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of December 14, 2018, is by and among RA Capital Management, LLC and Peter Kolchinsky (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • January 20th, 2015 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of January 20, 2015, is by and among RA Capital Management, LLC, Peter Kolchinsky and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 23rd, 2016 • Ra Capital Management, LLC • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of December 23, 2016, is by and among RA Capital Management, LLC, Peter Kolchinsky, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • April 7th, 2021 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of April 07, 2021, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 14th, 2024 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 28th, 2016 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of July 28, 2016, is by and among RA Capital Management, LLC, Peter Kolchinsky, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • June 7th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of June 7, 2024 is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 13, 2024 is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P., and the RA Capital Nexus Fund II, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • December 17th, 2020 • Ra Capital Management, L.P. • Services-medical laboratories
This Joint Filing Agreement, dated as of December 17, 2020, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 12th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 12, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 12th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 12, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • April 7th, 2021 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of April 07, 2021, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 14th, 2024 • Ra Capital Management, L.P. • Ophthalmic goods
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • May 24th, 2011 • Ra Capital Management, LLC • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agrees, as of May 24, 2011, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Tengion, Inc., and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • December 12th, 2014 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of December 12, 2014, is by and among RA Capital Management, LLC, Peter Kolchinsky and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • September 17th, 2019 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of September 17, 2019, is by and among RA Capital Management, LLC and Peter Kolchinsky (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • March 29th, 2021 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of March 29, 2021, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • March 30th, 2021 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of March 30, 2021, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GRa Capital Management, LLC • May 4th, 2007 • Biological products, (no disgnostic substances)
JOINT FILING AGREEMENTJoint Filing Agreement • July 2nd, 2018 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of July 2, 2018, is by and among RA Capital Management, LLC and Peter Kolchinsky (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 14th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 14th, 2024 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 14th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 14th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • January 29th, 2016 • Ra Capital Management, LLC • Surgical & medical instruments & apparatus
This Joint Filing Agreement, dated as of January 29, 2016, is by and among RA Capital Management, LLC, Peter Kolchinsky, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • August 13th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of August 13, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 10th, 2020 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of July 10, 2020, is by and among RA Capital Management, L.P., Peter Kolchinsky, and Rajeev Shah (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 14th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • August 13th, 2021 • Ra Capital Management, L.P. • Laboratory analytical instruments
This Joint Filing Agreement, dated as of August 13, 2021, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 27th, 2015 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of November 27, 2015, is by and among RA Capital Healthcare Fund, L.P., RA Capital Management, LLC, and Peter Kolchinsky (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 14th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTAgreement • February 14th, 2024 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
